These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22952625)

  • 1. HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola.
    Afonso JM; Bello G; Guimarães ML; Sojka M; Morgado MG
    PLoS One; 2012; 7(8):e42996. PubMed ID: 22952625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS; Cardoso LP; Stefani MM
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 diversity, transmission dynamics and primary drug resistance in Angola.
    Bártolo I; Zakovic S; Martin F; Palladino C; Carvalho P; Camacho R; Thamm S; Clemente S; Taveira N
    PLoS One; 2014; 9(12):e113626. PubMed ID: 25479241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic.
    Bártolo I; Rocha C; Bartolomeu J; Gama A; Marcelino R; Fonseca M; Mendes A; Epalanga M; Silva PC; Taveira N
    Infect Genet Evol; 2009 Jul; 9(4):672-82. PubMed ID: 18562253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis.
    Rojas Sánchez P; Domínguez S; Jiménez De Ory S; Prieto L; Rojo P; Mellado P; Navarro M; Delgado R; Ramos JT; Holguín Á;
    Pediatr Infect Dis J; 2018 Mar; 37(3):e48-e57. PubMed ID: 28991889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity and drug resistance of HIV-1 among infected pregnant women newly diagnosed in Luanda, Angola.
    Sebastião CS; Neto Z; de Jesus CS; Mirandela M; Jandondo D; Couto-Fernandez JC; Tanuri A; Morais J; Brito M
    PLoS One; 2019; 14(11):e0225251. PubMed ID: 31770425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
    Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 genetic variants circulation in the North of Angola.
    Abecasis A; Paraskevis D; Epalanga M; Fonseca M; Burity F; Bartolomeu J; Carvalho AP; Gomes P; Vandamme AM; Camacho R
    Infect Genet Evol; 2005 Apr; 5(3):231-7. PubMed ID: 15737914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
    Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
    AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
    J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Public Health Implications of HIV- Genetic Diversity and Drug Resistance Mutations in Angola: A Systematic Review.
    Sebastião CS; Morais J; Brito M
    AIDS Rev; 2020 Oct; 23(1):48-56. PubMed ID: 33105474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
    Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
    Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
    Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
    J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
    Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
    J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of unique recombinant forms of HIV-1 in Ghana: molecular epidemiology from an antiretroviral resistance study.
    Delgado E; Ampofo WK; Sierra M; Torpey K; Pérez-Alvarez L; Bonney EY; Mukadi YD; Lartey M; Nyarko C; Amenyah RN; Thomson M; Nájera R
    J Acquir Immune Defic Syndr; 2008 Aug; 48(5):599-606. PubMed ID: 18645511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.
    Epaulard O; Signori-Schmuck A; Larrat S; Kulkarni O; Blum MG; Fusillier K; Blanc M; Leclercq P; François O; Morand P
    J Clin Virol; 2017 Oct; 95():13-19. PubMed ID: 28830014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola.
    Garrido C; Zahonero N; Fernándes D; Serrano D; Silva AR; Ferraria N; Antúnes F; González-Lahoz J; Soriano V; de Mendoza C
    J Antimicrob Chemother; 2008 Mar; 61(3):694-8. PubMed ID: 18218644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia.
    Seu L; Mulenga LB; Siwingwa M; Sikazwe I; Lambwe N; Guffey MB; Chi BH
    J Med Virol; 2015 Jul; 87(7):1149-57. PubMed ID: 25754408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia.
    Dvali N; Parker MM; Chkhartishvili N; Sharvadze L; Gochitashvili N; Abutidze A; Karchava M; DeHovitz JA; Tsertsvadze T
    J Med Virol; 2012 Jul; 84(7):1002-8. PubMed ID: 22585715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.
    Ríos M; Delgado E; Pérez-Alvarez L; Fernández J; Gálvez P; de Parga EV; Yung V; Thomson MM; Nájera R
    J Med Virol; 2007 Jun; 79(6):647-56. PubMed ID: 17457921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.